FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3137337627> ?p ?o ?g. }

• W3137337627 abstract "Abstract Background Obstructive sleep apnoea (OSA) is very common in patients with type 2 diabetes (T2D). We and others have shown that OSA was associated with diabetes-related microvascular complications in patients with T2D in cross-sectional and longitudinal studies and that compliance with continuous positive airway pressure (CPAP) reduced the progression of microvascular complications. Hence, we hypothesised that adequate CPAP reduces the development of microvascular complication in patients with T2D. Methods SLEEP T2D is a cohort study with embedded feasibility, open-label, parallel-arm, randomised control trial (RCT) over 2 years. The primary aim is the feasibility of conducting a definitive RCT assessing the impact of CPAP on chronic kidney disease and other microvascular complications in patients with T2D. The main parameters are to assess willingness of participants to be randomised, follow-up rates, CPAP adherence/compliance, to optimise the choice of outcome measures for a substantive trial, and to identify the parameters for sample size calculations. The secondary aims of the study are related to the impact of CPAP, sleep-related disorders, and sleep chronotype on a variety of diabetes-related end points. The study participants were recruited from the T2D services in multiple NHS trusts across England. The main exclusion criteria for the cohort study are as follows: T1D, eGFR < 15 mL/min/1.73 m 2 , known OSA, active malignancy or chronic kidney disease from reasons other than diabetes, pregnancy, professional drivers, and a history of falling asleep whilst driving within last 2 years. The main exclusion criteria from the RCT were as follows: Apnoea-Hypopnoea Index < 10 and Epworth Sleepiness Score ≥ 11. Study participants were extensively phenotyped clinically and biochemically. The OSA diagnosis was based on multichannel portable device (ApneaLink Air TM , Resmed). Discussion The feasibility RCT will help us design the future RCT to assess the impact of CPAP on diabetes-related microvascular complications. The cohort study will generate preliminary data regarding the impact of sleep quality, duration, and chronotype on diabetes-related outcomes which could lead to further mechanistic and interventional studies. Trial registration ISRCTN, ISRCTN12361838 . Registered 04 April 2018, Protocol version: v5.0 02.12.19." @default.
• W3137337627 created "2021-03-29" @default.
• W3137337627 creator A5006243285 @default.
• W3137337627 creator A5006328603 @default.
• W3137337627 creator A5015149472 @default.
• W3137337627 creator A5025023179 @default.
• W3137337627 creator A5054980283 @default.
• W3137337627 creator A5068940588 @default.
• W3137337627 creator A5085398076 @default.
• W3137337627 creator A5090743194 @default.
• W3137337627 creator A5091390414 @default.
• W3137337627 date "2021-03-22" @default.
• W3137337627 modified "2023-10-18" @default.
• W3137337627 title "The impact of sleep disorders on microvascular complications in patients with type 2 diabetes (SLEEP T2D): the protocol of a cohort study and feasibility randomised control trial" @default.
• W3137337627 cites W10868135 @default.
• W3137337627 cites W1501531520 @default.
• W3137337627 cites W152234727 @default.
• W3137337627 cites W1858730046 @default.
• W3137337627 cites W1965060213 @default.
• W3137337627 cites W1967904505 @default.
• W3137337627 cites W1969865402 @default.
• W3137337627 cites W1970529956 @default.
• W3137337627 cites W1972056446 @default.
• W3137337627 cites W1979377205 @default.
• W3137337627 cites W1997274278 @default.
• W3137337627 cites W2003533532 @default.
• W3137337627 cites W2006033673 @default.
• W3137337627 cites W2009254187 @default.
• W3137337627 cites W2016758629 @default.
• W3137337627 cites W2028548148 @default.
• W3137337627 cites W2036579970 @default.
• W3137337627 cites W2038345436 @default.
• W3137337627 cites W2039248126 @default.
• W3137337627 cites W2044437167 @default.
• W3137337627 cites W2046048684 @default.
• W3137337627 cites W2105653766 @default.
• W3137337627 cites W2105720261 @default.
• W3137337627 cites W2108038374 @default.
• W3137337627 cites W2108496675 @default.
• W3137337627 cites W2112375249 @default.
• W3137337627 cites W2113524726 @default.
• W3137337627 cites W2113966285 @default.
• W3137337627 cites W2117834225 @default.
• W3137337627 cites W2120824707 @default.
• W3137337627 cites W2122310472 @default.
• W3137337627 cites W2126775711 @default.
• W3137337627 cites W2127111819 @default.
• W3137337627 cites W2128196669 @default.
• W3137337627 cites W2131787970 @default.
• W3137337627 cites W2151012450 @default.
• W3137337627 cites W2154777157 @default.
• W3137337627 cites W2154999423 @default.
• W3137337627 cites W2159506378 @default.
• W3137337627 cites W2160629168 @default.
• W3137337627 cites W2161509242 @default.
• W3137337627 cites W2165183398 @default.
• W3137337627 cites W2272030694 @default.
• W3137337627 cites W2333343699 @default.
• W3137337627 cites W2334157197 @default.
• W3137337627 cites W2405585158 @default.
• W3137337627 cites W2471605942 @default.
• W3137337627 cites W2483520518 @default.
• W3137337627 cites W2508221593 @default.
• W3137337627 cites W2526646214 @default.
• W3137337627 cites W2605530250 @default.
• W3137337627 cites W2612940703 @default.
• W3137337627 cites W26912437 @default.
• W3137337627 cites W2785224980 @default.
• W3137337627 cites W2889428857 @default.
• W3137337627 cites W2890331730 @default.
• W3137337627 cites W2897604532 @default.
• W3137337627 cites W2901426009 @default.
• W3137337627 cites W2911351998 @default.
• W3137337627 cites W3018652897 @default.
• W3137337627 doi "https://doi.org/10.1186/s40814-021-00817-z" @default.
• W3137337627 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7982768" @default.
• W3137337627 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33752759" @default.
• W3137337627 hasPublicationYear "2021" @default.
• W3137337627 type Work @default.
• W3137337627 sameAs 3137337627 @default.
• W3137337627 citedByCount "2" @default.
• W3137337627 countsByYear W31373376272022 @default.
• W3137337627 crossrefType "journal-article" @default.
• W3137337627 hasAuthorship W3137337627A5006243285 @default.
• W3137337627 hasAuthorship W3137337627A5006328603 @default.
• W3137337627 hasAuthorship W3137337627A5015149472 @default.
• W3137337627 hasAuthorship W3137337627A5025023179 @default.
• W3137337627 hasAuthorship W3137337627A5054980283 @default.
• W3137337627 hasAuthorship W3137337627A5068940588 @default.
• W3137337627 hasAuthorship W3137337627A5085398076 @default.
• W3137337627 hasAuthorship W3137337627A5090743194 @default.
• W3137337627 hasAuthorship W3137337627A5091390414 @default.
• W3137337627 hasBestOaLocation W31373376271 @default.
• W3137337627 hasConcept C126322002 @default.
• W3137337627 hasConcept C134018914 @default.
• W3137337627 hasConcept C168563851 @default.
• W3137337627 hasConcept C1862650 @default.
• W3137337627 hasConcept C187212893 @default.
• W3137337627 hasConcept C201903717 @default.
• W3137337627 hasConcept C2776006263 @default.

• next